Literature DB >> 19716965

Screening for and early detection of chronic obstructive pulmonary disease.

Joan B Soriano1, Jan Zielinski, David Price.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a substantially underdiagnosed disorder, with the diagnosis typically missed or delayed until the condition is advanced. Spirometry is the most frequently used pulmonary function test and enables health professionals to make an objective measurement of airflow obstruction and assess the degree to which it is reversible. As a diagnostic test for COPD, spirometry is a reliable, simple, non-invasive, safe, and non-expensive procedure. Early diagnosis of COPD should provide support for smoking cessation initiatives and lead to reduction of the societal burden of the disease, but definitive confirmation of both proves elusive. Despite substantial effort and investment, implementation of quality spirometry is deficient because of several hurdles and limitations, described in this Review. All in all, spirometry is recognised as the essential test for diagnosis and monitoring of COPD.

Entities:  

Mesh:

Year:  2009        PMID: 19716965     DOI: 10.1016/S0140-6736(09)61290-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  99 in total

1.  Roflumilast.

Authors:  Leonardo M Fabbri; Bianca Beghé; Uma Yasothan; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

2.  Spirometry: an essential tool for screening, case-finding, and diagnosis of COPD.

Authors:  Erika J Sims; David Price
Journal:  Prim Care Respir J       Date:  2012-06

3.  Overdiagnosis of COPD: precise definitions and proposals for improvement.

Authors:  Alberto Fernández-Villar; Joan B Soriano; José Luis López-Campos
Journal:  Br J Gen Pract       Date:  2017-04       Impact factor: 5.386

4.  The 'missing millions': Where do we find them?

Authors:  Nawar Diar Bakerly; Glenn Cardwell
Journal:  Chron Respir Dis       Date:  2016-11       Impact factor: 2.444

Review 5.  Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

Authors:  Andrea P Rossi; Erika Zanardi; Mauro Zamboni; Andrea Rossi
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

6.  Veterans Airflow Obstruction Screening Questionnaire: A Survey to Identify Veterans with Airflow Obstruction.

Authors:  Folarin Sogbetun; Wlliam L Eschenbacher; Jeffrey A Welge; Ralph J Panos
Journal:  Chronic Obstr Pulm Dis       Date:  2016-08-03

7.  Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease.

Authors:  Yusuke Nakade; Tadashi Toyama; Kengo Furuichi; Shinji Kitajima; Noriyuki Ohkura; Akihiro Sagara; Yasuyuki Shinozaki; Akinori Hara; Kiyoki Kitagawa; Miho Shimizu; Yasunori Iwata; Hiroyasu Oe; Mikio Nagahara; Hiroshi Horita; Yoshio Sakai; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-12-15       Impact factor: 2.801

8.  Awareness of COPD in a high risk Korean population.

Authors:  Jae Yong Seo; Yong Il Hwang; So Yeong Mun; Jin Hee Kim; Joo Hee Kim; Sung Hoon Park; Seung Hun Jang; Yong Bum Park; Jae Jung Shim; Ki-Suck Jung
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

Review 9.  Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.

Authors:  David B Price; Barbara P Yawn; Rupert C M Jones
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

10.  Emphysema diagnosis using X-ray dark-field imaging at a laser-driven compact synchrotron light source.

Authors:  Simone Schleede; Felix G Meinel; Martin Bech; Julia Herzen; Klaus Achterhold; Guillaume Potdevin; Andreas Malecki; Silvia Adam-Neumair; Sven F Thieme; Fabian Bamberg; Konstantin Nikolaou; Alexander Bohla; Ali Ö Yildirim; Roderick Loewen; Martin Gifford; Ronald Ruth; Oliver Eickelberg; Maximilian Reiser; Franz Pfeiffer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.